Acadia Healthcare Company Inc (NASDAQ:ACHC) Stock Is Shorted More

Investors sentiment increased to 1.58 in 2019 Q1. Its up 0.64, from 0.94 in 2018Q4. It improved, as 23 investors sold Acadia Healthcare Company, Inc. shares while 53 reduced holdings. 35 funds opened positions while 85 raised stakes. 102.09 million shares or 3.11% more from 99.01 million shares in 2018Q4 were reported.
7,000 were accumulated by New Jersey Better Educational Savings. Bbva Compass Savings Bank owns 7,288 shares or 0.01% of their US portfolio. Bank & Trust Of Montreal Can stated it has 13,310 shares. Nordea Investment Management Ab reported 140,136 shares or 0.01% of all its holdings. Glenmede Tru Company Na has invested 0% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Tiaa Cref Investment Management Llc stated it has 169,814 shares. South Dakota Invest Council holds 10,300 shares. State Common Retirement Fund invested 0.01% of its portfolio in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Royal State Bank Of Canada holds 0% or 379,009 shares. The Connecticut-based Ellington Mgmt Grp Ltd Limited Liability Company has invested 0.24% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Blair William And Company Il stated it has 0% of its portfolio in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Susquehanna Llp has invested 0% of its portfolio in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Capital Fund Mngmt Sa holds 0.01% or 37,600 shares. Prudential Fincl owns 698,476 shares for 0.03% of their portfolio. Us Commercial Bank De has invested 0% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC).

The stock of Acadia Healthcare Company Inc (NASDAQ:ACHC) registered an increase of 14.98% in short interest. ACHC’s total short interest was 14.48M shares in July as published by FINRA. Its up 14.98% from 12.59M shares, reported previously. With 1.01 million shares average volume, it will take short sellers 14 days to cover their ACHC’s short positions. The short interest to Acadia Healthcare Company Inc’s float is 16.82%.

The stock decreased 0.33% or $0.11 during the last trading session, reaching $33.51. About 526,092 shares traded. Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has declined 20.33% since July 14, 2018 and is downtrending. It has underperformed by 24.76% the S&P500.

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico. The company has market cap of $2.97 billion. The companyÂ’s acute inpatient psychiatric facilities offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities include residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs. It currently has negative earnings. It also provides outpatient community services, such as community programs that are designed to provide therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorder.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Ratings Coverage

Among 7 analysts covering Acadia Healthcare (NASDAQ:ACHC), 4 have Buy rating, 0 Sell and 3 Hold. Therefore 57% are positive. Acadia Healthcare has $45 highest and $3300 lowest target. $37.38’s average target is 11.55% above currents $33.51 stock price. Acadia Healthcare had 13 analyst reports since March 1, 2019 according to SRatingsIntel. The company was maintained on Thursday, June 20 by Raymond James. The stock of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has “Buy” rating given on Monday, March 11 by Stephens. Robert W. Baird maintained it with “Neutral” rating and $38 target in Monday, March 4 report. Citigroup maintained the stock with “Buy” rating in Monday, March 4 report. The stock of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) earned “Buy” rating by RBC Capital Markets on Monday, March 4. On Monday, March 4 the stock rating was maintained by Credit Suisse with “Hold”. Robert W. Baird maintained the stock with “Hold” rating in Friday, March 1 report. The stock has “Hold” rating by BMO Capital Markets on Tuesday, March 5. The rating was maintained by Raymond James on Monday, March 4 with “Buy”.

More notable recent Acadia Healthcare Company, Inc. (NASDAQ:ACHC) news were published by: Finance.Yahoo.com which released: “Is Acadia Healthcare Company Inc (ACHC) A Good Stock To Buy? – Yahoo Finance” on June 19, 2019, also Seekingalpha.com with their article: “Source: UnitedHealth Group Ruling And New Documents Establish Acadia Healthcare’s Liability In The Case Of Missing Mom/Teacher – Seeking Alpha” published on March 12, 2019, Nasdaq.com published: “Noteworthy Tuesday Option Activity: VMC, LYV, ACHC – Nasdaq” on June 11, 2019. More interesting news about Acadia Healthcare Company, Inc. (NASDAQ:ACHC) were released by: Bizjournals.com and their article: “Brentwood health care firm reaches $17 million settlement in fraud case – Nashville Business Journal” published on May 07, 2019 as well as Businesswire.com‘s news article titled: “Acadia Healthcare to Present at Credit Suisse 27th Annual Healthcare Conference – Business Wire” with publication date: November 08, 2018.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.